1. Home
  2. FUTU vs NBIX Comparison

FUTU vs NBIX Comparison

Compare FUTU & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Futu Holdings Limited

FUTU

Futu Holdings Limited

HOLD

Current Price

$123.63

Market Cap

14.7B

Sector

Finance

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$152.86

Market Cap

15.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUTU
NBIX
Founded
2011
1992
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.7B
15.5B
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
FUTU
NBIX
Price
$123.63
$152.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
22
Target Price
$217.75
$180.91
AVG Volume (30 Days)
1.1M
1.4M
Earning Date
05-28-2026
05-05-2026
Dividend Yield
3.39%
N/A
EPS Growth
N/A
41.95
EPS
N/A
3.30
Revenue
N/A
$161,626,000.00
Revenue This Year
$27.96
$24.73
Revenue Next Year
$11.89
$13.14
P/E Ratio
$17.05
$46.34
Revenue Growth
N/A
977.51
52 Week Low
$80.50
$122.14
52 Week High
$202.53
$186.12

Technical Indicators

Market Signals
Indicator
FUTU
NBIX
Relative Strength Index (RSI) 73.00 37.25
Support Level $91.06 $152.67
Resistance Level $155.54 $161.29
Average True Range (ATR) 4.26 4.10
MACD 1.28 -1.08
Stochastic Oscillator 98.34 21.47

Price Performance

Historical Comparison
FUTU
NBIX

About FUTU Futu Holdings Limited

Futu Holdings Ltd is an online broker providing one-stop online investing services.. Through its proprietary digital platforms, Futubull and Moomoo, the Company provides a full range of investment services, including trade execution and clearing, margin financing and securities lending, and wealth management. The Group engages in online brokerage services and margin financing services. It generates its revenue in the form of brokerage commission and handling charge services, and interest income. Geographically, it operates in Hong Kong, which derives key revenue and it also has its presence in other countries.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: